Slingshot Therapeutics
PrivateLast Round
Accelerator
Nov 13, 2024
Total Funding Raised
$15.89M
Company Overview
Slingshot Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in November 2024.
Slingshot Therapeutics is a biotechnology company that operates as a medicines accelerator to identify, de-risk, and advance early-stage therapeutic programmes from academic research institutions toward clinical development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Slingshot Therapeutics Comparables
Compare Slingshot Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argobio | 80% | |
| Science Creates | 76% | |
| Midlands Mindforge | 73% |
For institutional investors. Book with your work email.
Slingshot Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Slingshot Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Grew 43% QoQ from 7 to 10 employees.
- Jul 23, 2025
Grew 60% QoQ, from 5 to 8 employees.
For institutional investors. Book with your work email.
Slingshot Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Slingshot Therapeutics's valuation, stock price, and market status.
Is Slingshot Therapeutics a public or private company?
Slingshot Therapeutics is a private company.
What is the current stock price of Slingshot Therapeutics?
Slingshot Therapeutics is a private company, so its shares have no public market price. Caplight tracks Slingshot Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Slingshot Therapeutics worth (valuation)?
Valuation information for Slingshot Therapeutics is not publicly available.
Can I buy Slingshot Therapeutics stock?
Slingshot Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Slingshot Therapeutics's last funding round?
Slingshot Therapeutics's most recent funding round was Accelerator on November 13, 2024.
Who are the main investors in Slingshot Therapeutics?
Key investors in Slingshot Therapeutics include Syncona.
Will Slingshot Therapeutics IPO soon?
No public IPO plans have been announced for Slingshot Therapeutics.
How can I track Slingshot Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Slingshot Therapeutics's shares on secondary markets.